QDEL · QuidelOrtho Corp · Webcasts, Transcripts & Audio
$10.74
+0.12 (+1.13%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$736.90M
Shares
68.61M
Volume · Nov 13
2.04M
Avg daily vol (3M)
1.9M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
QuidelOrtho Corp Webcasts
Earnings calls, investor updates, investor days and conferences for QuidelOrtho Corp (QDEL), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-03
QuidelOrtho Corp (QDEL) Q3 2026 Earnings Call Transcript
Revenue
$618.90M
▼ 11.6% YoY Diluted EPS
$-0.78
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-06
QuidelOrtho Corp (QDEL) Q2 2026 Earnings Call Transcript
Cautious tone
China IBD pricing headwinds
Respiratory season softness
Cost reduction, cash flow and leverage
Revenue
$630.90M
▲ 2.8% YoY Diluted EPS
$-1.36
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
QuidelOrtho Corp (QDEL) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
QuidelOrtho Corp (QDEL) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
QuidelOrtho Corp (QDEL) Q1 2026 Earnings Call Transcript
Positive tone
Respiratory business
2026 financial guidance
Leadership transition
Revenue
$619.80M
▼ 10.5% YoY Diluted EPS
$-1.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-03
QuidelOrtho Corp (QDEL) March 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-11
QuidelOrtho Corp (QDEL) Q4 2025 Earnings Call Transcript
Positive tone
2026 guidance and free cash flow
R&D pipeline and FDA clearances
Leadership transition (CFO retirement)
Revenue
$723.60M*
▲ 2.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
QuidelOrtho Corp (QDEL) Q3 2025 Earnings Call Transcript
Confident tone
Margin improvement and cost savings
Donor screening business wind-down
Point-of-care and Triage business
Revenue
$699.90M
▼ 3.7% YoY Diluted EPS
$-10.78
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
QuidelOrtho Corp (QDEL) Q2 2025 Earnings Call
Revenue
$613.90M
▼ 3.6% YoY Diluted EPS
$-3.77
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Transcript
Confident tone
China business dynamics
Full year 2025 guidance
Tariff impact and mitigation
Revenue
$692.80M
▼ 2.6% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-12
QuidelOrtho Corp (QDEL) Q4 2024 Earnings Call Transcript
Positive tone
Geographic / China dynamics
Tariffs exposure
Cost reduction and profitability
Revenue
$707.80M*
▼ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
QuidelOrtho Corp (QDEL) Q3 2024 Earnings Call Transcript
Positive tone
China market dynamics
Cost savings and margin improvement
Respiratory season outlook
Revenue
$727.10M
▼ 2.3% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
QuidelOrtho Corp (QDEL) Q2 2024 Earnings Call Transcript
Positive tone
Savanna and menu pipeline
Core non-respiratory growth
Cost savings and efficiency
Revenue
$637.00M
▼ 4.2% YoY Diluted EPS
$-2.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
QuidelOrtho Corp (QDEL) Q1 2024 Earnings Call Transcript
Balanced tone
Savanna molecular platform
China and international growth
COVID-19 revenue outlook
Revenue
$711.00M
▼ 16% YoY Diluted EPS
$-25.50
▼ 3593.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
QuidelOrtho Corp (QDEL) Q4 2023 Earnings Call Transcript
Balanced tone
2024 Financial Guidance
Savanna Molecular Platform
Respiratory Season & COVID/Flu Outlook
Revenue
$742.60M*
▼ 14.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
QuidelOrtho Corp (QDEL) Q3 2023 Earnings Call Transcript
Revenue
$744.00M
▼ 5.1% YoY Diluted EPS
$-0.19
▼ 167.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
QuidelOrtho Corp (QDEL) Q2 2023 Earnings Call Transcript
Revenue
$665.10M
▲ 8.4% YoY Diluted EPS
$-0.80
▼ 322.2% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
QuidelOrtho Corp (QDEL) Q1 2023 Earnings Call Transcript
Revenue
$846.10M
▼ 15.6% YoY Diluted EPS
$0.73
▼ 93.5% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-15
QuidelOrtho Corp (QDEL) Q4 2022 Earnings Call Transcript
Revenue
$866.50M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
QuidelOrtho Corp (QDEL) Q3 2022 Earnings Call Transcript
Revenue
$783.80M
▲ 53.7% YoY Diluted EPS
$0.28
▼ 94.5% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
QuidelOrtho Corp (QDEL) Q2 2022 Earnings Call Transcript
Revenue
$613.40M
▲ 247.3% YoY Diluted EPS
$0.36
▼ 20% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
QuidelOrtho Corp (QDEL) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
QuidelOrtho Corp (QDEL) Q3 2021 Earnings Call Transcript
Revenue
$509.80M
Diluted EPS
$5.08
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
QuidelOrtho Corp (QDEL) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-18
QuidelOrtho Corp (QDEL) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q1
2020-05-06
QuidelOrtho Corp (QDEL) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–26 of 26 webcasts
Key facts
CIK
1906324
CUSIP
219798105
13F (30d)
187 filings
166 filers
Visit website
Investor relations